PCM
DERM icon

Prelude Capital Management’s Journey Medical DERM Stock Holding History

Prelude Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140K Buy
+29,894
New +$232K 0.01% 991
2024
Q2 		– Sell
-15,060
Closed -$55.4K – 1275
2024
Q1 		$55.4K Buy
+15,060
New +$65.5K ﹤0.01% 1250

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prelude Capital Management's DERM Position: Q1 2026 in Review

Prelude Capital Management opened a new position in Journey Medical (DERM) in Q1 2026: 29,894 shares worth $140K. The stake represents 0.01% of the portfolio and ranks #991 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in DERM as recently as Q1 2024.

Prelude Capital Management first reported a position in DERM in Q1 2024 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Prelude Capital Management held 29,894 shares of Journey Medical worth $140K as of Q1 2026.
  • Journey Medical was a new Prelude Capital Management position in Q1 2026.
  • Journey Medical made up 0.01% of Prelude Capital Management's portfolio in Q1 2026, its #991 holding.
  • Prelude Capital Management first reported a position in Journey Medical in Q1 2024 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.